Injectable Peptides Gain Popularity Among Biohackers

Grey-market injectable peptides, including BPC-157 and GHK-Cu, gain popularity among biohackers and health enthusiasts despite being unregulated. Journalist Adrienne Matei and Dr Anna Barnard from Imperial College London discuss their rise and potential effects on health in a recent podcast episode.

Read the full story at The Guardian AU→